An overview of the genetics, mechanisms and management of NAFLD and ALD.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical medicine (London)

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.7861/clinmedicine.15-6-s77PMID 26634687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.

  2015cited by this paper
• TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?

  2015cited by this paper
• Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

  2014cited by this paper
• Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.

  2014cited by this paper
• TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

  2014cited by this paper
• Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk

  2014cited by this paper
• Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

  2014cited by this paper
• Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification

  2013cited by this paper
• The genetics of NAFLD

  2013cited by this paper
• Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease.

  2013cited by this paper
• Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

  2013cited by this paper
• Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification

  2013cited by this paper
• Connectivity-based neurofeedback: Dynamic causal modeling for real-time fMRI☆

  2013cited by this paper
• Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

  2013cited by this paper
• Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice

  2012cited by this paper
• Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

  2012cited by this paper
• Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.

  2012cited by this paper
• Multigenerational Epigenetic Adaptation of the Hepatic Wound-Healing Response

  2012cited by this paper
• Genetic determinants of alcoholic liver disease

  2011cited by this paper
• The PNPLA3 rs738409 148M/M Genotype Is a Risk Factor for Liver Cancer in Alcoholic Cirrhosis but Shows No or Weak Association in Hepatitis C Cirrhosis

  2011cited by this paper
• Genetics of alcoholic and nonalcoholic fatty liver disease.

  2011cited by this paper
• Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

  2011cited by this paper
• Alcoholic liver disease and malnutrition.

  2011cited by this paper
• Genetic modifiers of non-alcoholic fatty liver disease progression.

  2011cited by this paper
• How big a problem is non-alcoholic fatty liver disease?

  2011cited by this paper
• Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

  2011cited by this paper
• A meta‐analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

  2010cited by this paper
• Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

  2010cited by this paper
• Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

  2010cited by this paper
• The importance of fatty liver disease in clinical practice

  2010cited by this paper
• Epidemiology of Non-Alcoholic Fatty Liver Disease

  2010cited by this paper
• Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

  2010cited by this paper
• Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies

  2010cited by this paper
• Epidemiology and natural history of non-alcoholic steatohepatitis.

  2009cited by this paper
• A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis

  2009cited by this paper
• Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

  2008cited by this paper
• Obstructive sleep apnea and nonalcoholic fatty liver disease: causal association or just a coincidence?

  2008cited by this paper
• Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

  2008cited by this paper
• The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

  2007cited by this paper
• Liver fat in the metabolic syndrome.

  2007cited by this paper
• Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

  2007cited by this paper
• Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

  2006cited by this paper
• Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study

  2005cited by this paper
• Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

  2003cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

  year unknowncited by this paper

• Serum β-klotho is a potential biomarker for diagnosing alcoholic liver disease and differentiating from nonalcoholic fatty liver disease

  2025cites this paper
• Exploring Cirrhosis: Insights into Advances in Therapeutic Strategies

  2025cites this paper
• Genomic Exploration of Nonalcoholic Fatty Liver Disease: Insights From Gene Expression and Variation in Morbidly Obese Individuals

  2025cites this paper
• The Relationships Between MASLD, Extrahepatic Multimorbidity, and All-Cause Mortality in the UK Biobank Cohort

  2025cites this paper
• Non-alcohlic Fatty Liver Disease (NAFLD): Is it a Dormant Volcano or Tip of an Iceberg?

  2024cites this paper
• Shear Wave Dispersion Elastography in ALD and MASLD: Comparative Pathophysiology and Clinical Potential—A Narrative Review

  2024cites this paper
• Metabolic Dysfunction Associated Steatotic Liver Disease: Current Practice, Screening Guidelines and Management in the Primary Care Setting.

  2023cites this paper
• Opportunities and considerations for studying liver disease with microphysiological systems on a chip.

  2023cites this paper
• Racial Disparities in Associations of Alcohol Consumption With Liver Disease Mortality in a Predominantly Low-Income Population: A Report From the Southern Community Cohort Study

  2022cites this paper
• Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine

  2022cites this paper
• Morphofunctional State and Circadian Rhythms of the Liver of Female Rats under the Influence of Chronic Alcohol Intoxication and Constant Lighting

  2022cites this paper
• Investigating the Protective Effects of a Rhenium (V) Compound with Uracil-Derived Ligands on Liver Damage Associated with Prediabetes in Diet-Induced Prediabetic Rats

  2022cites this paper
• Wnt/beta-catenin signaling and its modulators in nonalcoholic fatty liver diseases.

  2022cites this paper
• Higher Weight Variability Could Bring You a Fatty Liver

  2021cites this paper
• Morphofunctional State and Circadian Rhythms of the Liver under the Influence of Chronic Alcohol Intoxication and Constant Lighting

  2021cites this paper
• Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?

  2021cites this paper
• Effect of silibinin on ethanol- or acetaldehyde-induced damge of mouse primary hepatocytes in vitro.

  2020cites this paper
• Oxymatrine attenuates lipid accumulation in HepG 2 cells by inducing autophagy

  2019cites this paper
• Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease

  2019influential citation
• Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population

  2019cites this paper
• NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice

  2019cites this paper
• Oncogenic activation of Nrf2 by specific knockout of Nrf1α that acts as a dominant tumor repressor

  2018cites this paper
• Optimizing therapy of liver diseases not associated with viral infection.

  2018cites this paper
• Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor Repressor

  2018cites this paper
• The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais

  2018cites this paper
• Liver X receptor (cid:2) induces 17 (cid:3) -hydroxysteroid dehydrogenase-13 expression through SREBP-1c

  2017cites this paper
• Treatment options for alcoholic and non-alcoholic fatty liver disease: A review

  2017cites this paper
• Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers

  2017cites this paper
• Liver X receptor α induces 17β-hydroxysteroid dehydrogenase-13 expression through SREBP-1c.

  2017cites this paper
• From lowering plasma lipids to fight atherosclerosis to studies into the biogenesis of apoB-containing lipoproteins and their relationship with hepatic steatosis

  year unknowncites this paper